- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00502658
Dietary Supplements and Personal Energy Tracking Device to Promote and Maintain Healthy Weight
Evaluation of Dietary Supplements (Shakes and Supplements) and Personal Energy Tracking Device to Promote and Maintain Healthy Weight
Excessive body weight is becoming a concern around the world, for example over half of the American adult population is overweight or obese. The purpose of this study is to determine whether dietary supplements and shakes containing a combination of nutrients/ingredients individually shown in research studies to reduce hunger, enhance metabolism, reduce the body's ability to 'store' fat, and enhance energy, promote healthy body weight and composition over 12 weeks. A further study objective is to determine whether the inclusion of a personal, easy to use, energy tracking device for the measurement of daily energy intake and expenditure also helps with the promotion of healthy body weight and body composition.
In this prospective, blinded study 120 volunteers who meet the entrance criteria including a BMI 25-35 kg/m2 and sign the informed consent form to participate in a 12 week long study will be recruited. All subjects will consume a multi-vitamin, mineral and fish oil supplement. Subjects will be randomly assigned to a control or experimental group and stratified by BMI 25-30 and >30-35 kg/m2, age, and gender with an equal number of subjects in each strata across groups. A subset of subjects will also wear a personal energy tracking device. Subjects will be instructed how to incorporate the shakes and supplements into their current diet and encouraged to incorporate fruits, vegetables, whole grains, and other healthy foods into their current meals and to exercise at least 30 minutes five days per week.
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Utah
-
Provo, Utah, United States, 84601
- Pharmanex
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Between the ages of 18-65 years of age.
- Body Mass Index (BMI) between 25-35
- Willing to stop taking any nutritional supplements
Exclusion Criteria:
- Currently taking weight loss medication or supplements
- Currently smoke
- Taking any prescription medications
- Experienced at least a 10 pound weight loss over the past 2 months.
- History of serious heart problems (i.e. heart attack, angina, bypass surgery).
- Diagnosed with diabetes (insulin or non-insulin dependent)
- Known history of gastrointestinal diseases (i.e. Crohn's disease, chronic diarrhea, Inflammatory Bowel Disease)
- Undergone surgical procedure for weight loss (i.e. gastroplasty, gastric by-pass, gastrectomy, stomach stapling, gastric banding, etc).
- History of stroke or seizure activity
- Medical conditions known to affect serum lipids
- History of uncontrolled hypertension or with a current measured blood pressure with diastolic above 90 or systolic above 140 mm Hg
- A total serum cholesterol above 240 mg/dL
- Known HIV infection
- Known history of depression and currently taking anti-depression medications
- Treated for cancer in the last 5 years
- Known allergies to supplements
- Known history of eating disorder (i.e. bulimia, anorexia nervosa)
- Known severe swallowing disorders
- For females, known to be pregnant or breast-feeding or trying to become pregnant
- Participating in another clinical (medical or nutritional) study or likely to be enrolled in another medical or nutritional protocol during this study
Study Plan
How is the study designed?
Design Details
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Body weight changes
Time Frame: Several measurements over 12 weeks
|
Several measurements over 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Biophotonic scanner score, blood chemistry and metabolic profiles, adverse events, subjects' supplement preference, quality of life measurements
Time Frame: Several measurements over 12 weeks
|
Several measurements over 12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Doug Burke, PhD, Pharmanex
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 007-001, WIRB 20070167
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.